PGDx lands another $42 million in funding
October 05, 2018 at 11:17 AM EDT
PGDx’s is developing in vitro diagnostic (IVD) genome testing, or tests that can be used to analyze the DNA of tumors, to cancer patients worldwide.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.